Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort studyMin Zhang, Guozhong Gong, Guangdi Li et al.|Hepatology International|2020Cited by 33
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 TrialYanhang Gao, Junqi Niu, Huanyu Gong et al.|Clinical Infectious Diseases|2021Cited by 15
Functional cure based on pegylated interferon alpha therapy in nucleoside analog-suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest Project in China)-3.5 years data updateChan Xie, Zhiliang Gao, Dong‐Ying Xie et al.|Journal of Hepatology|2022Cited by 7
Pradefovir in naive or experienced adult patients with chronic infection of hepatitis B virus: week24 results from 23 multicentre, double-blind, randomised, non-inferiority, phase2 trialsYanhang Gao, Junqi Niu, Fei Kong et al.|Journal of Hepatology|2020Cited by 0